Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Sunday, May 3, 2020
Louisiana Board of Pharmacy Legislative Proposals for 2020
2020-C ~ Amends the definition of "pharmacy collaborative drug therapy management" in the Pharmacy Practice Act, and further, enacts a new section in that same law which creates limited prescriptive authority for pharmacists.
01-22-2020 - Regulation Revision Committee reviewed Draft #4, requested one amendment, then voted to recommend the approval of Draft #5 to the Board.
02-05-2020 - Board approved Draft #5 for filing.
2020-B ~ Amends the state controlled substances law, to add additional drugs to various schedules, consistent with state and federal scheduling actions.
01-22-2020 - Regulation Revision Committee voted to recommend the approval of Draft #2 to the Board.
02-05-2020 - Board approved Draft #2 for filing.
02-17-2020 - Incorporated in HB 89; prefiled for 2020 Regular Session.
2020-A ~ Amends different sections of the Pharmacy Practice Act to enable the changing of renewal cycles for licenses and permits from annual to biennial; amended to add permit fees for pharmacy benefit managers.
10-17-2019 - Regulation Revision Committee voted to recommend the approval of Draft #1 to the Board.
11-13-2019 - Draft #1 approved for filing by the Board.
02-05-2020 - Board reconsidered the vote by which they approved Draft #1 in November 2019, then considered Draft #2. The members requested one amendment, then voted to approve Draft #3 for filing.
02-28-2020 - incorporated in HB 619; prefiled for 2020 Regular Session.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment